Welcome to MS Views and News blog


MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

July 8, 2026

AI Reveals Hidden Gray Matter Lesions in Multiple Sclerosis

  • Grey Matter Lesions
    /
  • MS Research Study and Reports
    /
Summary: An international team of scientists and clinicians developed a generative artificial intelligence framework that unmasks these previously hidden cortical lesions…
Grey Matter Lesions

June 29, 2026

7 Self-Care Tips for Multiple Sclerosis

  • Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)
    /
  • MS Diet & Nutrition
    /
  • MS Exercise, Yoga, Tai Chi, Pilates
    /
Multiple sclerosis (MS) is a neurological condition that affects the function of the central nervous system. MS can be an…
Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)

June 29, 2026

MS Exercises for Better Balance and Coordination

  • MS Exercise, Yoga, Tai Chi, Pilates
    /
Key takeaways • Exercises and physical activity can help people with MS maintain balance, reduce muscle tightness, and improve their…
MS Exercise, Yoga, Tai Chi, Pilates

June 27, 2026

Improving access to NMOSD diagnosis: Multicenter evaluation of the iDOT AQP4 assay

  • NMO (NMOSD/Devics)
    /
  • NMOSD
    /
Matteo Gastaldi – AAN2026 Disclosures: Matteo Gastaldi is on the advisory board for UCB, @Alexion, Roche, J&J, and Argenx. New…
NMO (NMOSD/Devics)

June 27, 2026

GLP-1 therapies and cognitive impairment: New data highlights possible “survival paradox”

  • MS Cognition
    /
  • Misc. MS Related
    /
  • Misc. Research Reports
    /
Isaac Thorman, Fawaz Al-Muft — AAN2026 Findings from AAN 2026 highlight a potential “survival paradox” associated with GLP-1 analogue use…
MS Cognition

June 26, 2026

New research findings challenge old beliefs about myelin repair in MS

  • Myelin Repair
    /
  • MS Research Study and Reports
    /
Study reveals myelin-making cells are constantly being produced Written by Marisa Wexler, MS Oligodendrocytes, the cells responsible for making myelin, are constantly…
Myelin Repair

June 26, 2026

FDA OKs first human trial of oral MS remyelination therapy PTD802

  • Myelin Repair
    /
  • MS Research Study and Reports
    /
New US study to evaluate treatment’s safety, tolerability in healthy volunteers Written by Michela Luciano, PhD | June 25, 2026 The U.S. Food…
Myelin Repair

June 23, 2026

Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU (European Union) as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses

  • BTK Inhibitors
    /
  • Cenrifki (tolebrutinib)
    /
  • MS Drug Therapies
    /
Paris, June 23, 2026. The European Commission has approved Cenrifki (tolebrutinib) for the treatment of secondary progressive multiple sclerosis (SPMS)…
BTK Inhibitors

June 19, 2026

FDA clears CTA313 (Car-T Cellular Therapy) trial for progressive MS, autoimmune disease

  • CAR-T therapy
    /
  • MS Research Study and Reports
    /
Basket study will test off-the-shelf CAR T-cell therapy in 3 conditions Written by Patricia Inacio, PhD | June 12, 2026 Imviva Biotech is cleared…
CAR-T therapy

June 19, 2026

Multiple Sclerosis or Lupus: Can You Have Both?

  • LUPUS
    /
  • AutoImmune Diseases
    /
Multiple sclerosis and lupus can have some overlapping symptoms, but they’re two distinct conditions. Read on to find out more…
LUPUS

Categories

Latest Blog Posts